FC(F)(F)C(O)=O.O=C1C2C(=CC=CC=2)C(=O)[N:10]1[CH2:19][C:20]1[S:24][C:23]([NH:25][C:26]2[CH:27]=[C:28]([CH:44]=[CH:45][CH:46]=2)[CH2:29][NH:30][C:31]2[C:40]3[C:35](=[C:36]([C:41]([NH2:43])=[O:42])[CH:37]=[CH:38][CH:39]=3)[N:34]=[CH:33][N:32]=2)=[N:22][CH:21]=1.O.NN>C(O)C>[NH2:10][CH2:19][C:20]1[S:24][C:23]([NH:25][C:26]2[CH:27]=[C:28]([CH:44]=[CH:45][CH:46]=2)[CH2:29][NH:30][C:31]2[C:40]3[C:35](=[C:36]([C:41]([NH2:43])=[O:42])[CH:37]=[CH:38][CH:39]=3)[N:34]=[CH:33][N:32]=2)=[N:22][CH:21]=124 mg (0.04 mmol) 4-{3-[5-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-thiazol-2-ylamino]-benzylamino}-quinazoline-8-carboxylic acid amide trifluoroacetic acid salt were dissolved in 1 ml ethanol and treated with 10 μl (0.21 mmol) hydrazine hydrate. The mixture was stirred overnight at 50° C. in a closed vessel. Additional 40 μl hydrazine hydrate were added and the mixture was stirred at 60° C. for 24 h. The reaction mixture was evaporated and the crude product was purified using preparative HPLC. The product was treated with HCl in methanol and concentrated in the SpeedVac.
Loading…